Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 126 entries
Sorted by: Best Match Show Resources per page
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51.

Cell death and differentiation

Manic G, Musella M, Corradi F, Sistigu A, Vitale S, Soliman Abdel Rehim S, Mattiello L, Malacaria E, Galassi C, Signore M, Pallocca M, Scalera S, Goeman F, De Nicola F, Guarracino A, Pennisi R, Antonangeli F, Sperati F, Baiocchi M, Biffoni M, Fanciulli M, Maugeri-Saccà M, Franchitto A, Pichierri P, De Maria R, Vitale I.
PMID: 33531658
Cell Death Differ. 2021 Jul;28(7):2060-2082. doi: 10.1038/s41418-020-00733-4. Epub 2021 Feb 02.

Cancer stem cells (CSCs) are tumor subpopulations driving disease development, progression, relapse and therapy resistance, and their targeting ensures tumor eradication. CSCs display heterogeneous replication stress (RS), but the functionality/relevance of the RS response (RSR) centered on the ATR-CHK1...

Cite
Manic G, Musella M, Corradi F, et al. Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51. Cell Death Differ. 2021;28(7):2060-2082doi: 10.1038/s41418-020-00733-4.
Manic, G., Musella, M., Corradi, F., Sistigu, A., Vitale, S., Soliman Abdel Rehim, S., Mattiello, L., Malacaria, E., Galassi, C., Signore, M., Pallocca, M., Scalera, S., Goeman, F., De Nicola, F., Guarracino, A., Pennisi, R., Antonangeli, F., Sperati, F., Baiocchi, M., Biffoni, M., Fanciulli, M., Maugeri-Saccà, M., Franchitto, A., Pichierri, P., De Maria, R., & Vitale, I. (2021). Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51. Cell death and differentiation, 28(7), 2060-2082. https://doi.org/10.1038/s41418-020-00733-4
Manic, Gwenola, et al. "Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51." Cell death and differentiation vol. 28,7 (2021): 2060-2082. doi: https://doi.org/10.1038/s41418-020-00733-4
Manic G, Musella M, Corradi F, Sistigu A, Vitale S, Soliman Abdel Rehim S, Mattiello L, Malacaria E, Galassi C, Signore M, Pallocca M, Scalera S, Goeman F, De Nicola F, Guarracino A, Pennisi R, Antonangeli F, Sperati F, Baiocchi M, Biffoni M, Fanciulli M, Maugeri-Saccà M, Franchitto A, Pichierri P, De Maria R, Vitale I. Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51. Cell Death Differ. 2021 Jul;28(7):2060-2082. doi: 10.1038/s41418-020-00733-4. Epub 2021 Feb 02. PMID: 33531658; PMCID: PMC8257675.
Copy Download .nbib Format: NLM
Polarimetric imaging microscopy for advanced inspection of vegetal tissues.

Scientific reports

Van Eeckhout A, Garcia-Caurel E, Garnatje T, Escalera JC, Durfort M, Vidal J, Gil JJ, Campos J, Lizana A.
PMID: 33594126
Sci Rep. 2021 Feb 16;11(1):3913. doi: 10.1038/s41598-021-83421-8.

Optical microscopy techniques for plant inspection benefit from the fact that at least one of the multiple properties of light (intensity, phase, wavelength, polarization) may be modified by vegetal tissues. Paradoxically, polarimetric microscopy although being a mature technique in...

Cite
Van Eeckhout A, Garcia-Caurel E, Garnatje T, et al. Polarimetric imaging microscopy for advanced inspection of vegetal tissues. Sci Rep. 2021;11(1):3913doi: 10.1038/s41598-021-83421-8.
Van Eeckhout, A., Garcia-Caurel, E., Garnatje, T., Escalera, J. C., Durfort, M., Vidal, J., Gil, J. J., Campos, J., & Lizana, A. (2021). Polarimetric imaging microscopy for advanced inspection of vegetal tissues. Scientific reports, 11(1), 3913. https://doi.org/10.1038/s41598-021-83421-8
Van Eeckhout, Albert, et al. "Polarimetric imaging microscopy for advanced inspection of vegetal tissues." Scientific reports vol. 11,1 (2021): 3913. doi: https://doi.org/10.1038/s41598-021-83421-8
Van Eeckhout A, Garcia-Caurel E, Garnatje T, Escalera JC, Durfort M, Vidal J, Gil JJ, Campos J, Lizana A. Polarimetric imaging microscopy for advanced inspection of vegetal tissues. Sci Rep. 2021 Feb 16;11(1):3913. doi: 10.1038/s41598-021-83421-8. PMID: 33594126; PMCID: PMC7887219.
Copy Download .nbib Format: NLM
Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study.

Basic research in cardiology

Díaz-Munoz R, Valle-Caballero MJ, Sanchez-Gonzalez J, Pizarro G, García-Rubira JC, Escalera N, Fuster V, Fernández-Jiménez R, Ibanez B.
PMID: 34279726
Basic Res Cardiol. 2021 Jul 19;116(1):45. doi: 10.1007/s00395-021-00884-6.

Besides its protective effect against neutrophil-mediated injury at reperfusion, intravenous (IV) metoprolol was recently shown to reduce the progression of ischemic injury in a pig model of ST-segment elevation myocardial infarction (STEMI). Here, we tested the hypothesis that IV...

Cite
Díaz-Munoz R, Valle-Caballero MJ, Sanchez-Gonzalez J, et al. Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study. Basic Res Cardiol. 2021;116(1):45doi: 10.1007/s00395-021-00884-6.
Díaz-Munoz, R., Valle-Caballero, M. J., Sanchez-Gonzalez, J., Pizarro, G., García-Rubira, J. C., Escalera, N., Fuster, V., Fernández-Jiménez, R., & Ibanez, B. (2021). Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study. Basic research in cardiology, 116(1), 45. https://doi.org/10.1007/s00395-021-00884-6
Díaz-Munoz, Raquel, et al. "Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study." Basic research in cardiology vol. 116,1 (2021): 45. doi: https://doi.org/10.1007/s00395-021-00884-6
Díaz-Munoz R, Valle-Caballero MJ, Sanchez-Gonzalez J, Pizarro G, García-Rubira JC, Escalera N, Fuster V, Fernández-Jiménez R, Ibanez B. Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study. Basic Res Cardiol. 2021 Jul 19;116(1):45. doi: 10.1007/s00395-021-00884-6. PMID: 34279726.
Copy Download .nbib Format: NLM
Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms Challenge.

IEEE transactions on medical imaging

Campello VM, Gkontra P, Izquierdo C, Martin-Isla C, Sojoudi A, Full PM, Maier-Hein K, Zhang Y, He Z, Ma J, Parreno M, Albiol A, Kong F, Shadden SC, Acero JC, Sundaresan V, Saber M, Elattar M, Li H, Menze B, Khader F, Haarburger C, Scannell CM, Veta M, Carscadden A, Punithakumar K, Liu X, Tsaftaris SA, Huang X, Yang X, Li L, Zhuang X, Vilades D, Descalzo ML, Guala A, Mura L, Friedrich MG, Garg R, Lebel J, Henriques F, Karakas M, Cavus E, Petersen SE, Escalera S, Segui S, Rodriguez-Palomares JF, Lekadir K.
PMID: 34138702
IEEE Trans Med Imaging. 2021 Dec;40(12):3543-3554. doi: 10.1109/TMI.2021.3090082. Epub 2021 Nov 30.

The emergence of deep learning has considerably advanced the state-of-the-art in cardiac magnetic resonance (CMR) segmentation. Many techniques have been proposed over the last few years, bringing the accuracy of automated segmentation close to human performance. However, these models...

Cite
Campello VM, Gkontra P, Izquierdo C, et al. Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms Challenge. IEEE Trans Med Imaging. 2021;40(12):3543-3554doi: 10.1109/TMI.2021.3090082.
Campello, V. M., Gkontra, P., Izquierdo, C., Martin-Isla, C., Sojoudi, A., Full, P. M., Maier-Hein, K., Zhang, Y., He, Z., Ma, J., Parreno, M., Albiol, A., Kong, F., Shadden, S. C., Acero, J. C., Sundaresan, V., Saber, M., Elattar, M., Li, H., Menze, B., Khader, F., Haarburger, C., Scannell, C. M., Veta, M., Carscadden, A., Punithakumar, K., Liu, X., Tsaftaris, S. A., Huang, X., Yang, X., Li, L., Zhuang, X., Vilades, D., Descalzo, M. L., Guala, A., Mura, L., Friedrich, M. G., Garg, R., Lebel, J., Henriques, F., Karakas, M., Cavus, E., Petersen, S. E., Escalera, S., Segui, S., Rodriguez-Palomares, J. F., & Lekadir, K. (2021). Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms Challenge. IEEE transactions on medical imaging, 40(12), 3543-3554. https://doi.org/10.1109/TMI.2021.3090082
Campello, Victor M, et al. "Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms Challenge." IEEE transactions on medical imaging vol. 40,12 (2021): 3543-3554. doi: https://doi.org/10.1109/TMI.2021.3090082
Campello VM, Gkontra P, Izquierdo C, Martin-Isla C, Sojoudi A, Full PM, Maier-Hein K, Zhang Y, He Z, Ma J, Parreno M, Albiol A, Kong F, Shadden SC, Acero JC, Sundaresan V, Saber M, Elattar M, Li H, Menze B, Khader F, Haarburger C, Scannell CM, Veta M, Carscadden A, Punithakumar K, Liu X, Tsaftaris SA, Huang X, Yang X, Li L, Zhuang X, Vilades D, Descalzo ML, Guala A, Mura L, Friedrich MG, Garg R, Lebel J, Henriques F, Karakas M, Cavus E, Petersen SE, Escalera S, Segui S, Rodriguez-Palomares JF, Lekadir K. Multi-Centre, Multi-Vendor and Multi-Disease Cardiac Segmentation: The M&Ms Challenge. IEEE Trans Med Imaging. 2021 Dec;40(12):3543-3554. doi: 10.1109/TMI.2021.3090082. Epub 2021 Nov 30. PMID: 34138702.
Copy Download .nbib Format: NLM
Recovery opioid overdose team (ROOT) pilot program evaluation: A community-wide post-overdose response strategy.

Substance abuse

Dahlem CHG, Scalera M, Anderson G, Tasker M, Ploutz-Snyder R, McCabe SE, Boyd CJ.
PMID: 33284095
Subst Abus. 2021;42(4):423-427. doi: 10.1080/08897077.2020.1847239. Epub 2020 Dec 07.

No abstract available.

Cite
Dahlem CHG, Scalera M, Anderson G, et al. Recovery opioid overdose team (ROOT) pilot program evaluation: A community-wide post-overdose response strategy. Subst Abus. 2020;42(4):423-427doi: 10.1080/08897077.2020.1847239.
Dahlem, C. H. G., Scalera, M., Anderson, G., Tasker, M., Ploutz-Snyder, R., McCabe, S. E., & Boyd, C. J. (2021). Recovery opioid overdose team (ROOT) pilot program evaluation: A community-wide post-overdose response strategy. Substance abuse, 42(4), 423-427. https://doi.org/10.1080/08897077.2020.1847239
Dahlem, Chin Hwa Gina, et al. "Recovery opioid overdose team (ROOT) pilot program evaluation: A community-wide post-overdose response strategy." Substance abuse vol. 42,4 (2021): 423-427. doi: https://doi.org/10.1080/08897077.2020.1847239
Dahlem CHG, Scalera M, Anderson G, Tasker M, Ploutz-Snyder R, McCabe SE, Boyd CJ. Recovery opioid overdose team (ROOT) pilot program evaluation: A community-wide post-overdose response strategy. Subst Abus. 2021;42(4):423-427. doi: 10.1080/08897077.2020.1847239. Epub 2020 Dec 07. PMID: 33284095; PMCID: PMC8180524.
Copy Download .nbib Format: NLM
Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients.

Cell reports. Medicine

Aydillo T, Escalera A, Strohmeier S, Aslam S, Sanchez-Cespedes J, Ayllon J, Roca-Oporto C, Perez-Romero P, Montejo M, Gavalda J, Munoz P, Lopez-Medrano F, Carratala J, Krammer F, García-Sastre A, Cordero E.
PMID: 33294855
Cell Rep Med. 2020 Nov 03;1(8):100130. doi: 10.1016/j.xcrm.2020.100130. eCollection 2020 Nov 17.

Hemagglutination-inhibitory antibodies are usually highly strain specific with little effect on infection with drifted or shifted strains. The significance of broadly cross-reactive non-HAI anti-influenza antibodies against conserved domains of virus glycoproteins, such as the hemagglutinin (HA) stalk, is of...

Cite
Aydillo T, Escalera A, Strohmeier S, et al. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients. Cell Rep Med. 2020;1(8):100130doi: 10.1016/j.xcrm.2020.100130.
Aydillo, T., Escalera, A., Strohmeier, S., Aslam, S., Sanchez-Cespedes, J., Ayllon, J., Roca-Oporto, C., Perez-Romero, P., Montejo, M., Gavalda, J., Munoz, P., Lopez-Medrano, F., Carratala, J., Krammer, F., García-Sastre, A., & Cordero, E. (2020). Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients. Cell reports. Medicine, 1(8), 100130. https://doi.org/10.1016/j.xcrm.2020.100130
Aydillo, Teresa, et al. "Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients." Cell reports. Medicine vol. 1,8 (2020): 100130. doi: https://doi.org/10.1016/j.xcrm.2020.100130
Aydillo T, Escalera A, Strohmeier S, Aslam S, Sanchez-Cespedes J, Ayllon J, Roca-Oporto C, Perez-Romero P, Montejo M, Gavalda J, Munoz P, Lopez-Medrano F, Carratala J, Krammer F, García-Sastre A, Cordero E. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients. Cell Rep Med. 2020 Nov 03;1(8):100130. doi: 10.1016/j.xcrm.2020.100130. eCollection 2020 Nov 17. PMID: 33294855; PMCID: PMC7691380.
Copy Download .nbib Format: NLM
Action Recognition Using Single-Pixel Time-of-Flight Detection.

Entropy (Basel, Switzerland)

Ofodile I, Helmi A, Clapés A, Avots E, Peensoo KM, Valdma SM, Valdmann A, Valtna-Lukner H, Omelkov S, Escalera S, Ozcinar C, Anbarjafari G.
PMID: 33267128
Entropy (Basel). 2019 Apr 18;21(4). doi: 10.3390/e21040414.

Action recognition is a challenging task that plays an important role in many robotic systems, which highly depend on visual input feeds. However, due to privacy concerns, it is important to find a method which can recognise actions without...

Cite
Ofodile I, Helmi A, Clapés A, et al. Action Recognition Using Single-Pixel Time-of-Flight Detection. Entropy (Basel). 2019;21(4)doi: 10.3390/e21040414.
Ofodile, I., Helmi, A., Clapés, A., Avots, E., Peensoo, K. M., Valdma, S. M., Valdmann, A., Valtna-Lukner, H., Omelkov, S., Escalera, S., Ozcinar, C., & Anbarjafari, G. (2019). Action Recognition Using Single-Pixel Time-of-Flight Detection. Entropy (Basel, Switzerland), 21(4), . https://doi.org/10.3390/e21040414
Ofodile, Ikechukwu, et al. "Action Recognition Using Single-Pixel Time-of-Flight Detection." Entropy (Basel, Switzerland) vol. 21,4 (2019). doi: https://doi.org/10.3390/e21040414
Ofodile I, Helmi A, Clapés A, Avots E, Peensoo KM, Valdma SM, Valdmann A, Valtna-Lukner H, Omelkov S, Escalera S, Ozcinar C, Anbarjafari G. Action Recognition Using Single-Pixel Time-of-Flight Detection. Entropy (Basel). 2019 Apr 18;21(4). doi: 10.3390/e21040414. PMID: 33267128; PMCID: PMC7514902.
Copy Download .nbib Format: NLM
Observed and Expected Survival in Men and Women After Suffering a STEMI.

Journal of clinical medicine

Pascual I, Hernandez-Vaquero D, Almendarez M, Lorca R, Escalera A, Díaz R, Alperi A, Carnero M, Silva J, Morís C, Avanzas P.
PMID: 32325887
J Clin Med. 2020 Apr 19;9(4). doi: 10.3390/jcm9041174.

INTRODUCTION: Mortality caused by ST elevation myocardial infarction (STEMI) has declined because of greater use of primary percutaneous coronary intervention (PCI). It is unknown if patients >75 have similar survival as peers. We aim to know it stratifying by...

Cite
Pascual I, Hernandez-Vaquero D, Almendarez M, et al. Observed and Expected Survival in Men and Women After Suffering a STEMI. J Clin Med. 2020;9(4)doi: 10.3390/jcm9041174.
Pascual, I., Hernandez-Vaquero, D., Almendarez, M., Lorca, R., Escalera, A., Díaz, R., Alperi, A., Carnero, M., Silva, J., Morís, C., & Avanzas, P. (2020). Observed and Expected Survival in Men and Women After Suffering a STEMI. Journal of clinical medicine, 9(4), . https://doi.org/10.3390/jcm9041174
Pascual, Isaac, et al. "Observed and Expected Survival in Men and Women After Suffering a STEMI." Journal of clinical medicine vol. 9,4 (2020). doi: https://doi.org/10.3390/jcm9041174
Pascual I, Hernandez-Vaquero D, Almendarez M, Lorca R, Escalera A, Díaz R, Alperi A, Carnero M, Silva J, Morís C, Avanzas P. Observed and Expected Survival in Men and Women After Suffering a STEMI. J Clin Med. 2020 Apr 19;9(4). doi: 10.3390/jcm9041174. PMID: 32325887; PMCID: PMC7230566.
Copy Download .nbib Format: NLM
Interrelations of Oxygen Evolution and Iridium Dissolution Mechanisms.

Angewandte Chemie (International ed. in English)

Lončar A, Escalera D, Cherevko S, Hodnik N.
PMID: 34942052
Angew Chem Int Ed Engl. 2021 Dec 23; doi: 10.1002/anie.202114437. Epub 2021 Dec 23.

Widespread utilization of proton exchange membrane (PEM) electrolyzers is currently still uncertain, as it inevitably relies on the use of highly scarce iridium as the only viable catalyst for oxygen evolution reaction (OER), which is known to present the...

Cite
Lončar A, Escalera D, Cherevko S, et al. Interrelations of Oxygen Evolution and Iridium Dissolution Mechanisms. Angew Chem Int Ed Engl. 2021;doi: 10.1002/anie.202114437.
Lončar, A., Escalera, D., Cherevko, S., & Hodnik, N. (2021). Interrelations of Oxygen Evolution and Iridium Dissolution Mechanisms. Angewandte Chemie (International ed. in English), . https://doi.org/10.1002/anie.202114437
Lončar, Anja, et al. "Interrelations of Oxygen Evolution and Iridium Dissolution Mechanisms." Angewandte Chemie (International ed. in English) vol. (2021). doi: https://doi.org/10.1002/anie.202114437
Lončar A, Escalera D, Cherevko S, Hodnik N. Interrelations of Oxygen Evolution and Iridium Dissolution Mechanisms. Angew Chem Int Ed Engl. 2021 Dec 23; doi: 10.1002/anie.202114437. Epub 2021 Dec 23. PMID: 34942052.
Copy Download .nbib Format: NLM
Subchondral Bone Length in Knee Osteoarthritis: A Deep Learning-Derived Imaging Measure and Its Association With Radiographic and Clinical Outcomes.

Arthritis & rheumatology (Hoboken, N.J.)

Chang GH, Park LK, Le NA, Jhun RS, Surendran T, Lai J, Seo H, Promchotichai N, Yoon G, Scalera J, Capellini TD, Felson DT, Kolachalama VB.
PMID: 33973737
Arthritis Rheumatol. 2021 Dec;73(12):2240-2248. doi: 10.1002/art.41808. Epub 2021 Oct 29.

OBJECTIVE: To develop a bone shape measure that reflects the extent of cartilage loss and bone flattening in knee osteoarthritis (OA) and test it against estimates of disease severity.METHODS: A fast region-based convolutional neural network was trained to crop...

Cite
Chang GH, Park LK, Le NA, et al. Subchondral Bone Length in Knee Osteoarthritis: A Deep Learning-Derived Imaging Measure and Its Association With Radiographic and Clinical Outcomes. Arthritis Rheumatol. 2021;73(12):2240-2248doi: 10.1002/art.41808.
Chang, G. H., Park, L. K., Le, N. A., Jhun, R. S., Surendran, T., Lai, J., Seo, H., Promchotichai, N., Yoon, G., Scalera, J., Capellini, T. D., Felson, D. T., & Kolachalama, V. B. (2021). Subchondral Bone Length in Knee Osteoarthritis: A Deep Learning-Derived Imaging Measure and Its Association With Radiographic and Clinical Outcomes. Arthritis & rheumatology (Hoboken, N.J.), 73(12), 2240-2248. https://doi.org/10.1002/art.41808
Chang, Gary H, et al. "Subchondral Bone Length in Knee Osteoarthritis: A Deep Learning-Derived Imaging Measure and Its Association With Radiographic and Clinical Outcomes." Arthritis & rheumatology (Hoboken, N.J.) vol. 73,12 (2021): 2240-2248. doi: https://doi.org/10.1002/art.41808
Chang GH, Park LK, Le NA, Jhun RS, Surendran T, Lai J, Seo H, Promchotichai N, Yoon G, Scalera J, Capellini TD, Felson DT, Kolachalama VB. Subchondral Bone Length in Knee Osteoarthritis: A Deep Learning-Derived Imaging Measure and Its Association With Radiographic and Clinical Outcomes. Arthritis Rheumatol. 2021 Dec;73(12):2240-2248. doi: 10.1002/art.41808. Epub 2021 Oct 29. PMID: 33973737; PMCID: PMC8581065.
Copy Download .nbib Format: NLM
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).

European heart journal. Cardiovascular pharmacotherapy

Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B.
PMID: 34351426
Eur Heart J Cardiovasc Pharmacother. 2021 Aug 05; doi: 10.1093/ehjcvp/pvab060. Epub 2021 Aug 05.

BACKGROUND: There is a lack of evidence regarding the benefits of β-blocker treatment after invasively managed acute myocardial infarction (MI) without reduced left ventricular ejection fraction (LVEF).METHODS AND RESULTS: TREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fraction...

Cite
Rossello X, Raposeiras-Roubin S, Latini R, et al. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). Eur Heart J Cardiovasc Pharmacother. 2021;doi: 10.1093/ehjcvp/pvab060.
Rossello, X., Raposeiras-Roubin, S., Latini, R., Dominguez-Rodriguez, A., Barrabés, J. A., Sánchez, P. L., Anguita, M., Fernández-Vázquez, F., Pascual-Figal, D., De la Torre Hernandez, J. M., Ferraro, S., Vetrano, A., Pérez-Rivera, J. A., Prada-Delgado, O., Escalera, N., Staszewsky, L., Pizarro, G., Agüero, J., Pocock, S., Ottani, F., Fuster, V., Ibáñez, B. (2021). Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). European heart journal. Cardiovascular pharmacotherapy, . https://doi.org/10.1093/ehjcvp/pvab060
Rossello, Xavier, et al. "Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)." European heart journal. Cardiovascular pharmacotherapy vol. (2021). doi: https://doi.org/10.1093/ehjcvp/pvab060
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). Eur Heart J Cardiovasc Pharmacother. 2021 Aug 05; doi: 10.1093/ehjcvp/pvab060. Epub 2021 Aug 05. PMID: 34351426.
Copy Download .nbib Format: NLM
Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice.

Frontiers in pharmacology

Ardaiz N, Gomar C, Vasquez M, Tenesaca S, Fernandez-Sendin M, Di Trani CA, Belsué V, Escalada J, Werner U, Tennagels N, Berraondo P.
PMID: 33679386
Front Pharmacol. 2021 Feb 19;11:591293. doi: 10.3389/fphar.2020.591293. eCollection 2020.

No abstract available.

Cite
Ardaiz N, Gomar C, Vasquez M, et al. Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice. Front Pharmacol. 2021;11:591293doi: 10.3389/fphar.2020.591293.
Ardaiz, N., Gomar, C., Vasquez, M., Tenesaca, S., Fernandez-Sendin, M., Di Trani, C. A., Belsué, V., Escalada, J., Werner, U., Tennagels, N., & Berraondo, P. (2020). Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice. Frontiers in pharmacology, 11591293. https://doi.org/10.3389/fphar.2020.591293
Ardaiz, Nuria, et al. "Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice." Frontiers in pharmacology vol. 11 (2020): 591293. doi: https://doi.org/10.3389/fphar.2020.591293
Ardaiz N, Gomar C, Vasquez M, Tenesaca S, Fernandez-Sendin M, Di Trani CA, Belsué V, Escalada J, Werner U, Tennagels N, Berraondo P. Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice. Front Pharmacol. 2021 Feb 19;11:591293. doi: 10.3389/fphar.2020.591293. eCollection 2020. PMID: 33679386; PMCID: PMC7934061.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 126 entries